STOCK TITAN

BED BATH & BEYOND INC. REPORTS FISCAL 2022 FIRST QUARTER RESULTS (ENDING MAY 28th, 2022)

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Negative)
Tags
Rhea-AI Summary

Bed Bath & Beyond reported Q1 Fiscal 2022 results with net sales of $1,463M, a 25% decline from the previous year. Comparable sales dropped 23%, with the Bed Bath & Beyond banner seeing a 27% decrease. The GAAP gross margin was 23.9%, impacted by transient costs, while adjusted gross margin was 23.8%. The company faced a net loss of $358M, translating to a diluted EPS of ($4.49). CEO Sue Gove highlighted efforts to optimize inventory and cost structures amidst challenging market conditions.

Positive
  • Sequential comparable sales recovery expected in second half of Fiscal 2022.
  • Cost structure adjustments anticipated to align with lower sales.
  • Capital expenditures reduced to approximately $300 million.
Negative
  • Net sales down 25% year-over-year.
  • Comparable sales decline of 23% reflects shifting consumer behavior.
  • Significant net loss of $358M for the quarter.

Net Sales of $1,463M; Comparable Sales of (23)% Consistent with Early Quarter Trends as Previously Shared
GAAP Gross Margin of 23.9%; Adjusted Gross Margin of 23.8% including 840bps Impact from Transient Costs Related to Inventory Markdown Reserves and Port-Related Supply Chain Fees
Excluding the Two Aforementioned Impacts, Q1 Adjusted Gross Margin of 32.2%
Announcing Aggressive Actions on Inventory, Cost and Capex

UNION, N.J., June 29, 2022 /PRNewswire/ -- Bed Bath & Beyond Inc. (Nasdaq: BBBY) today reported financial results for the first quarter of Fiscal 2022 ended May 28, 2022.


Reported (GAAP)


Adjusted2

($ in millions, except per share data)

Three months ended


Three months ended


May 28, 2022

May 29, 2021

Diff


May 28, 2022

May 29, 2021

Diff

Net Sales

$1,463

$1,954

(25) %


$1,463

$1,954

(25) %

Comparable1 Sales







(23) %

Gross Margin

23.9 %

32.4 %

-850bps


23.8 %

34.9 %

-1,110bps









SG&A Margin

43.6 %

33.7 %

990bps


43.6 %

33.7 %

990bps

Net (Loss) Income

($358)

($51)

($307)


($225)

$5

($230)

Adjusted2 EBITDA





($224)

$86

($310)

Adjusted2 EBITDA Margin





(15.3) %

4.4 %

-1,970bps

EPS - Diluted

($4.49)

($0.48)

($4.01)


($2.83)

$0.05

($2.88)

 

As announced earlier today in a separate press release, Sue Gove has been named Interim Chief Executive Officer, replacing Mark Tritton, who will leave his role as President and Chief Executive Officer and as a member of the Board. 

Ms. Gove commented, "I step into this role keenly aware of the macro-economic environment. In the quarter there was an acute shift in customer sentiment and, since then, pressures have materially escalated. This includes steep inflation and fluctuations in purchasing patterns, leading to significant dislocation in our sales and inventory that we will be working to actively resolve. The simple reality though is that our first quarter's results are not up to our expectations, nor are they reflective of the Company's true potential. The initiatives we are instituting today are just the first steps in putting our business on firm footing to drive our future success. I look forward to working with the Board, the management team, and our Associates to immediately address our supply chain challenges, market share recapture, inventory and cash optimization, and cost structure alignment."

Q1 Highlights

  • Net Sales of $1,463M declined (25)%, reflecting a Comparable1 Sales decline of (23)% and (2)% related to the impact from fleet optimization activity
    • Bed Bath & Beyond banner Comparable1 Sales decline of (27)% reflecting rapid shift in consumer spending patterns and declining demand in Home sector
    • buybuy BABY Comparable1 Sales of down mid-single digits commensurate with current market decline; Market share remains stable
  • GAAP Gross Margin of 23.9%; Adjusted2 Gross Margin of 23.8%
    • Adjusted2 Gross Margin reflects 840bps of negative transient costs vs. Q1 2021
    • Transient costs reflect the impact of an inventory markdown reserve of (620bps) and supply chain-related port fees of (220bps)
    • Excluding the aforementioned 840bps of transient costs, Q1 Adjusted2 Gross Margin of 32.2%
  • Cash Flow from Operations of approximately $(0.4) billion, Cash Flow from Investing Activities of $(0.1) billion and Cash Flow from Financing Activities of $0.2 billion

Fiscal 2022 First Quarter Results (ending May 28, 2022)

Net sales of $1,463M declined (25)%, reflecting a Comparable1 Sales decline of (23)% and (2)% related to the impact from fleet optimization activity.

  • By channel, Comparable1 Sales declined (24)% in Stores and (21)% in Digital versus the fiscal 2021 first quarter.
  • Bed Bath & Beyond banner Comparable1 Sales decreased (27)% compared to the prior year period. Results exclude the impact from the Company's previously announced store fleet optimization program, which began in the second half of fiscal 2020.
  • The buybuy BABY banner Comparable1 Sales decreased in the mid-single digits compared to the Fiscal 2021 first quarter consistent with market trends.

GAAP Gross Margin was 23.9% for the quarter. Excluding special items, Adjusted2 Gross Margin was 23.8%, inclusive of transient costs associated with a 620 basis point negative impact from markdown inventory reserves and 220 basis point negative impact from supply chain-related port fees compared to last year.  Excluding the aforementioned 840 basis points of transient costs, Q1 Adjusted2 Gross Margin was 32.2%.  The Company is proactively working with suppliers to adjust future inventory receipts and accelerating markdowns in order to right-size inventory levels commensurate with the declining sales trends.

SG&A expense on both a GAAP and Adjusted2 basis remain at lower levels compared to the prior year period, primarily due to cost reductions and lower rent and occupancy expenses on a lower store base following the Company's fleet optimization program.  SG&A Margin for the quarter increased on a GAAP and Adjusted2 basis versus last year due to lower Net Sales. Bed Bath & Beyond is in the midst of further refining its supply chain infrastructure and adjusting cost structure to reflect lower sales levels. At the same time, the Company is pausing its new store and remodel programs for the remainder of fiscal 2022 which is expected to reduce its Fiscal 2022 planned capital expenditures by a minimum of approximately $100 million to $300 million from a prior expectation of approximately $400 million.

Adjusted2 EBITDA for the period was ($224) million reflecting lower Net Sales and lower Adjusted2 Gross Margin.

Net Loss per diluted share of ($4.49) for the quarter reflected approximately $1.66 of special items for the quarter. Excluding special items, Adjusted2 Net Loss per diluted share was ($2.83). Special items during the first quarter included restructuring and costs associated with the Company's transformation initiatives.  Adjusted2 Net Loss per diluted share also reflects an income tax benefit on the Company's Adjusted2 Pre-Tax Loss.

During the quarter, the Company reported operating cash flow of approximately $(0.4) billion. Investing cash flow of $(0.1) billion was primarily driven by planned capital expenditures in connection with store remodels, supply chain and information technology systems. 

Cash, cash equivalents, restricted cash and investments totaled approximately $0.2 billion in the Fiscal 2022 first quarter. Total Liquidity3 was approximately $0.9 billion as of the Fiscal 2022 first quarter, including the Company's asset based revolving credit facility less borrowings of $0.2 billion. 

Fiscal 2022 Outlook Commentary

At this time, the Company is providing the following outlook parameters for Fiscal 2022:

–  Sequential Comparable1 Sales recovery to occur in the second half of Fiscal 2022 versus the first half of Fiscal 2022 driven by inventory optimization plans, including incremental clearance activity

–  Adjusted2 SG&A expense for Fiscal 2022 below last year, reflecting aggressive actions to align cost structure to sales

–  Capital Expenditures of approximately $300 million (from $400 million previously) for Fiscal 2022, reflecting a minimum reduction of $100 million

The Company will provide further commentary and context for its Fiscal 2022 outlook during its conference call as well as in its investor presentation available on the investor relations section of the Company's website at http://bedbathandbeyond.gcs-web.com/investor-relations.

Fiscal 2022 First Quarter Conference Call and Investor Presentation

Bed Bath & Beyond Inc.'s Fiscal 2022 first quarter conference call with analysts and investors will be held today at 8:15am EDT and may be accessed by dialing 1-404-400-0571, or if international, 1-866-374-5140, using conference ID number 80961020#. A live audio webcast of the conference call, along with the earnings press release, investor presentation and supplemental financial disclosures, will also be available on the investor relations section of the Company's website at http://bedbathandbeyond.gcs-web.com/investor-relations. The webcast will be available for replay after the call.

The Company has also made available an Investor Presentation on the investor relations section of the Company's website at http://bedbathandbeyond.gcs-web.com/events-and-presentations.

(1)

Comparable Sales reflects the year-over-year change in sales from the Company's retail channels, including stores and digital, that have been operating for twelve full months following the opening period (typically six to eight weeks). Comparable Sales excludes the impact of the Company's store network optimization program.



(2)

Adjusted items refer to comparable sales as well as financial measures that are derived from measures calculated in accordance with GAAP, which have been adjusted to exclude certain items. Adjusted Gross Margin, Adjusted SG&A, Adjusted EBITDA, Adjusted EBITDA Margin, and Adjusted EPS - Diluted are non-GAAP financial measures.  For more information about non-GAAP financial measures, see "Non-GAAP Information" below.



(3)

Total Liquidity includes cash & investments and availability under the Company's asset-based revolving credit facility.

 

 

About the Company

Bed Bath & Beyond Inc. and subsidiaries (the "Company") is an omnichannel retailer that makes it easy for our customers to feel at home. The Company sells a wide assortment of merchandise in the Home, Baby, Beauty and Wellness markets.  Additionally, the Company is a partner in a joint venture which operates retail stores in Mexico under the name Bed Bath & Beyond.

The Company operates websites at bedbathandbeyond.com, bedbathandbeyond.ca, buybuybaby.com, buybuybaby.ca, harmondiscount.com, facevalues.com, and decorist.com. As of May 28, 2022, the Company had a total of 955 stores, including 769 Bed Bath & Beyond stores in all 50 states, the District of Columbia, Puerto Rico and Canada, 135 buybuy BABY stores and 51 stores under the names Harmon, Harmon Face Values or Face Values. During the Fiscal 2022 first quarter, the Company opened 5 buybuy BABY stores. Additionally during the fiscal 2022 first quarter, the Company closed 3 stores including 2 Bed Bath & Beyond stores and 1 Harmon store. The joint venture to which the Company is a partner operates 12 stores in Mexico under the name Bed Bath & Beyond.

Non-GAAP Information

This press release contains certain non-GAAP information, including adjusted earnings before interest, income taxes, depreciation and amortization ("EBITDA"), adjusted EBITDA margin, adjusted gross margin, adjusted SG&A, adjusted net earnings per diluted share, and free cash flow. Non-GAAP information is intended to provide visibility into the Company's core operations and excludes special items, including non-cash impairment charges related to certain store-level assets and tradenames, loss on sale of businesses, loss on the extinguishment of debt, charges recorded in connection with the restructuring and transformation initiatives, which includes accelerated markdowns and inventory reserves related to the planned assortment transition to Owned Brands and costs associated with store closures related to the Company's fleet optimization and the income tax impact of these items. The Company's definition and calculation of non-GAAP measures may differ from that of other companies. Non-GAAP financial measures should be viewed in addition to, and not as an alternative for, the Company's reported GAAP financial results. For a reconciliation to the most directly comparable US GAAP measures and certain information relating to the Company's use of Non-GAAP financial measures, see "Non-GAAP Financial Measures" below.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21 E of the Securities Exchange Act of 1934 including, but not limited to, our progress and anticipated progress towards our long-term objectives, as well as more generally the status of our future liquidity and financial condition and our outlook for our 2022 Fiscal second quarter and 2022 Fiscal year. Many of these forward-looking statements can be identified by use of words such as may, will, expect, anticipate, approximate, estimate, assume, continue, model, project, plan, goal, preliminary, and similar words and phrases, although the absence of those words does not necessarily mean that statements are not forward-looking. Our actual results and future financial condition may differ materially from those expressed in any such forward-looking statements as a result of many factors. Such factors include, without limitation: general economic conditions including the recent supply chain disruptions, labor shortages, wage pressures, rising inflation and the ongoing military conflict between Russia and Ukraine; a challenging overall macroeconomic environment and a highly competitive retailing environment; risks associated with the ongoing COVID-19 pandemic and the governmental responses to it, including its impacts across our businesses on demand and operations, as well as on the operations of our suppliers and other business partners, and the effectiveness of our and governmental actions taken in response to these risks; changing consumer preferences, spending habits and demographics; demographics and other macroeconomic factors that may impact the level of spending for the types of merchandise sold by us; challenges in executing our omni-channel and transformation strategy, including our ability to establish and profitably maintain the appropriate mix of digital and physical presence in the markets we serve; our ability to successfully execute our store fleet optimization strategies, including our ability to achieve anticipated cost savings and to not exceed anticipated costs; our ability to execute on any additional strategic transactions and realize the benefits of any acquisitions, partnerships, investments or divestitures; disruptions to our information technology systems, including but not limited to security breaches of systems protecting consumer and employee information or other types of cybercrimes or cybersecurity attacks; damage to our reputation in any aspect of our operations; the cost of labor, merchandise, logistical costs and other costs and expenses; potential supply chain disruption due to trade restrictions or otherwise, and other factors such as natural disasters, pandemics, including the COVID-19 pandemic, political instability, labor disturbances, product recalls, financial or operational instability of suppliers or carriers, and other items; inflation and the related increases in costs of materials, labor and other costs; inefficient management of relationships and dependencies on third-party service providers; our ability to attract and retain qualified employees in all areas of the organization; unusual weather patterns and natural disasters, including the impact of climate change; uncertainty and disruptions in financial markets; volatility in the price of our common stock and its effect, and the effect of other factors, including the COVID-19 pandemic, on our capital allocation strategy; changes to statutory, regulatory and other legal requirements or deemed noncompliance with such requirements; changes to accounting rules, regulations and tax laws, or new interpretations of existing accounting standards or tax laws; new, or developments in existing, litigation, claims or assessments; and a failure of our business partners to adhere to appropriate laws, regulations or standards. Except as required by law, we do not undertake any obligation to update our forward-looking statements.

Contacts
INVESTOR CONTACT: Susie Kim, IR@bedbath.com
MEDIA CONTACT: Eric Mangan, media@bedbath.com

 

BED BATH & BEYOND INC. AND SUBSIDIARIES

Consolidated Statements of Operations

(in thousands, except per share data)

(unaudited)



Three Months Ended


May 28, 2022


May 29, 2021





Net sales

$      1,463,418


$      1,953,812





Cost of sales

1,114,106


1,320,118





    Gross profit

349,312


633,694





Selling, general and administrative expenses

637,508


658,762





Impairments

26,699


9,129





Restructuring and transformation initiative expenses

24,263


33,686





Loss on sale of businesses


3,989





    Operating loss

(339,158)


(71,872)





Interest expense, net

16,448


16,000





Loss on extinguishment of debt


265





    Loss before provision (benefit) for income taxes

(355,606)


(88,137)





Provision (benefit) for income taxes

2,060


(37,263)





    Net loss

$         (357,666)


$           (50,874)





Net loss per share - Basic

$               (4.49)


$               (0.48)

Net loss per share - Diluted

$               (4.49)


$               (0.48)





Weighted average shares outstanding - Basic

79,611


106,772

Weighted average shares outstanding - Diluted

79,611


106,772

 

Non-GAAP Financial Measures

The following table reconciles non-GAAP financial measures presented in this press release or that may be presented on the Company's first quarter conference call with analysts and investors. The Company believes that these non-GAAP financial measures provide management, analysts, investors and other users of the Company's financial information with meaningful supplemental information regarding the performance of the Company's business. These non-GAAP financial measures should not be considered superior to, but in addition to other financial measures prepared by the Company in accordance with GAAP, including comparisons of year-to-year results. The Company's method of determining these non-GAAP financial measures may be different from other companies' methods and, therefore, may not be comparable to those used by other companies. As such, the Company does not recommend the sole use of these non-GAAP measure to assess its financial and earnings performance. For reasons noted above, the Company is presenting certain non-GAAP financial measures for its Fiscal 2022 first quarter. In order for investors to be able to more readily compare the Company's performance across periods, the Company has included comparable reconciliations for the 2021 period in the reconciliation tables below. The Company is not providing a reconciliation of its guidance with respect to Adjusted EBITDA because the Company is unable to provide this reconciliation without unreasonable effort due to the uncertainty and inherent difficulty of predicting the occurrence, the financial impact, and the periods in which the adjustments may be recognized. For the same reasons, the Company is unable to address the probable significance of the unavailable information, which could be material to future results.

Non-GAAP Reconciliation

(in thousands, except per share data)

(unaudited)




Three Months Ended May 28, 2022





Excluding





Reported


Loss on Sale
of Businesses


Loss on
extinguishment
of debt


Restructuring
and
Transformation
Expenses


Impairments
charges


Total income
tax impact


Total Impact


Adjusted

Gross Profit


$     349,312


$               —


$                —


$          (1,167)


$               —


$               —


$        (1,167)


$       348,145

Gross margin


23.9 %


— %


— %


(0.1) %


— %


— %


(0.1) %


23.8 %


















Restructuring and transformation initiative expenses


24,263




(24,263)




(24,263)



















(Loss) earnings before provision (benefit) for income taxes


(355,606)




23,096


26,699



49,795


(305,811)


















Provision (benefit) for income taxes


2,060






(82,636)


(82,636)


(80,576)

Effective tax rate


(0.6) %










26.9 %


26.9 %


26.3 %


















Net (loss) income


$   (357,666)


$                 —


$                  —


$            23,096


$         26,699


$         82,636


$        132,431


$     (225,235)


















Net loss per share - Diluted


$           (4.49)












$              1.66


$           (2.83)


















Weighted average shares outstanding- Basic


79,611












79,611


79,611

Weighted average shares outstanding- Diluted


79,611

(1)











79,611


79,611


















Reconciliation of Net Income (loss) to EBITDA and Adjusted EBITDA









Net (loss) income


$    (357,666)


$                 —


$                  —


$            23,096


$         26,699


$         82,636


$       132,431


$     (225,235)

Depreciation and amortization


71,103




(5,275)




(5,275)


65,828

Interest expense


16,448








16,448

Provision (benefit) for income taxes


2,060






(82,636)


(82,636)


(80,576)

EBITDA


$    (268,055)


$                 —


$                  —


$            17,821


$         26,699


$                 —


$         44,520


$    (223,535)

EBITDA as % of net sales
















(15.3) %


















(1) If a company is in a net loss position, then for earnings per share purposes, diluted weighted average shares outstanding are equivalent to basic weighted average shares outstanding.

 



Three Months Ended May 29, 2021





Excluding





Reported


Loss on Sale
of Businesses


Loss on
extinguishment
of debt


Restructuring
and
Transformation
Expenses


Impairment
charges


Total income
tax impact


Total Impact


Adjusted

Gross Profit


$     633,694


$               —


$                —


$          47,344


$               —


$               —


$       47,344


$      681,038

Gross margin


32.4 %


— %


— %


2.4 %


— %


— %


2.4 %


34.9 %


















Restructuring and transformation initiative expenses


33,686




(33,686)




(33,686)



















(Loss) earnings before (benefit) provision for income taxes


(88,137)


3,989


265


81,030


9,129



94,413


6,276


















(Benefit) provision for income taxes


(37,263)






38,614


38,614


1,351

Effective tax rate


42.3 %










(20.8) %


(20.8) %


21.5 %


















Net (loss) income


$       (50,874)


$            3,989


$                265


$            81,030


$            9,129


$      (38,614)


$         55,799


$           4,925


















Net (loss) earnings per share - Diluted


$           (0.48)












$             0.53


$             0.05


















Weighted average shares outstanding- Basic


106,772












106,772


106,772

Weighted average shares outstanding- Diluted


106,772

(1)











106,772


109,029


















Reconciliation of Net (Loss) Income to EBITDA and Adjusted EBITDA









Net (loss) income


$      (50,874)


$            3,989


$                265


$            81,030


$            9,129


$        (38,614)


$         55,799


$           4,925

Depreciation and amortization


68,278




(4,484)




(4,484)


63,794

Loss on extinguishment of debt


265



(265)





(265)


Interest expense


16,000








16,000

(Benefit) provision for income taxes


(37,263)






38,614


38,614


1,351

EBITDA


$         (3,594)


$            3,989


$                  —


$            76,546


$            9,129


$                 —


$         89,664


$        86,070

EBITDA as % of net sales
















4.4 %


















(1) If a company is in a net loss position, then for earnings per share purposes, diluted weighted average shares outstanding are equivalent to basic weighted average shares outstanding.

 

 

BED BATH & BEYOND INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(in thousands, except per share data)



May 28,
2022


February 26,
2022


May 29,
2021


(unaudited)




(unaudited)

Assets






Current assets:






    Cash and cash equivalents

$            107,543


$            439,496


$        1,097,267

    Short term investment securities



29,997

    Merchandise inventories

1,759,586


1,725,410


1,563,602

    Prepaid expenses and other current assets

190,179


198,248


515,993

        Total current assets

2,057,308


2,363,154


3,206,859

Long term investment securities

18,983


19,212


19,458

Property and equipment, net

1,119,247


1,027,387


929,335

Operating lease assets

1,597,461


1,562,857


1,584,144

Other assets

156,103


157,962


313,493

Total Assets

$         4,949,102


$         5,130,572


$         6,053,289

Liabilities and Shareholders' (Deficit) Equity






Current liabilities:






    Accounts payable

$            816,578


$            872,445


$            889,883

    Accrued expenses and other current liabilities

549,754


529,371


506,674

    Merchandise credit and gift card liabilities

325,232


326,465


309,576

    Current operating lease liabilities

334,891


346,506


347,365

        Total current liabilities

2,026,455


2,074,787


2,053,498

Other liabilities

111,085


102,438


78,353

Operating lease liabilities

1,561,870


1,508,002


1,529,173

Income taxes payable

90,120


91,424


102,905

Long term debt

1,379,870


1,179,776


1,182,566

        Total liabilities

5,169,400


4,956,427


4,946,495

Shareholders' (deficit) equity:






Preferred stock - $0.01 par value; authorized - 1,000 shares; no shares issued or outstanding



Common stock - $0.01 par value; authorized - 900,000 shares; issued 344,621, 344,146 and 343,570, respectively; outstanding 79,958, 81,979 and 104,513 shares, respectively

3,446


3,441


3,435

Additional paid-in capital

2,243,378


2,235,894


2,208,052

Retained earnings

9,308,530


9,666,091


10,174,656

Treasury stock, at cost; 264,663, 262,167 and 239,057 shares, respectively

(11,728,295)


(11,685,267)


(11,234,529)

Accumulated other comprehensive loss

(47,357)


(46,014)


(44,820)

Total shareholders' (deficit) equity

(220,298)


174,145


1,106,794

Total liabilities and shareholders' (deficit) equity

$        4,949,102


$        5,130,572


$        6,053,289

 

 

BED BATH & BEYOND INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(in thousands, unaudited)



Three Months Ended


May 28, 2022


May 29, 2021

Cash Flows from Operating Activities:




  Net loss

$            (357,666)


$             (50,874)

  Adjustments to reconcile net loss to net cash used in operating activities:




    Depreciation and amortization

71,103


68,278

    Impairments

26,699


9,129

    Stock-based compensation

7,123


7,918

    Deferred income taxes

(2,299)


(22,135)

    Loss on sale of businesses


3,989

    Loss on debt extinguishment


265

    Other

590


(2,197)

    (Increase) decrease in assets:




        Merchandise inventories

(34,757)


113,366

        Other current assets

7,971


78,544

        Other assets

(106)


68

    (Decrease) increase in liabilities:




        Accounts payable

(47,597)


(102,201)

        Accrued expenses and other current liabilities

(38,038)


(129,327)

        Merchandise credit and gift card liabilities

(1,176)


(3,421)

        Income taxes payable

(1,304)


277

        Operating lease assets and liabilities, net

(13,096)


3,125

        Other liabilities

(998)


(3,545)

  Net cash used in operating activities

(383,551)


(28,741)





Cash Flows from Investing Activities:




    Purchases of held-to-maturity investment securities


(29,997)

    Capital expenditures

(104,852)


(73,521)

  Net cash used in  investing activities

(104,852)


(103,518)





Cash Flows from Financing Activities:




    Borrowing of long-term debt

200,000


    Repayments of long-term debt


(8,173)

    Repurchase of common stock, including fees

(43,028)


(138,695)

    Payment of dividends

(271)


(560)

  Net cash provided by (used in) financing activities

156,701


(147,428)





  Effect of exchange rate changes on cash, cash equivalents and restricted cash

(251)


6,117





Net decrease in cash, cash equivalents and restricted cash

(331,953)


(273,570)





Cash, cash equivalents and restricted cash:




  Beginning of period

470,884


1,407,224

  End of period

$             138,931


$          1,133,654

 

Cision View original content:https://www.prnewswire.com/news-releases/bed-bath--beyond-inc-reports-fiscal-2022-first-quarter-results-ending-may-28th-2022-301577609.html

SOURCE Bed Bath & Beyond Inc.

FAQ

What were Bed Bath & Beyond's net sales for Q1 Fiscal 2022?

Net sales for Q1 Fiscal 2022 were $1,463 million.

What was the comparable sales decline reported by Bed Bath & Beyond?

The comparable sales decline was 23%.

What is the expected outcome for comparable sales in the second half of Fiscal 2022?

A sequential recovery in comparable sales is expected in the second half of Fiscal 2022.

What was the adjusted gross margin reported for Q1 Fiscal 2022?

The adjusted gross margin for Q1 Fiscal 2022 was 23.8%.

How much was the net loss per diluted share for Bed Bath & Beyond in Q1?

The net loss per diluted share was ($4.49).

BBBY

NASDAQ:BBBY

BBBY Rankings

BBBY Latest News

BBBY Stock Data

41.96M
116.39M
0.31%
11.93%
24.24%
Specialty Retail
Consumer Cyclical
Link
United States
Union